eLife (Sep 2016)

DPP9 is a novel component of the N-end rule pathway targeting the tyrosine kinase Syk

  • Daniela Justa-Schuch,
  • Maria Silva-Garcia,
  • Esther Pilla,
  • Michael Engelke,
  • Markus Kilisch,
  • Christof Lenz,
  • Ulrike Möller,
  • Fumihiko Nakamura,
  • Henning Urlaub,
  • Ruth Geiss-Friedlander

DOI
https://doi.org/10.7554/eLife.16370
Journal volume & issue
Vol. 5

Abstract

Read online

The aminopeptidase DPP9 removes dipeptides from N-termini of substrates having a proline or alanine in second position. Although linked to several pathways including cell survival and metabolism, the molecular mechanisms underlying these outcomes are poorly understood. We identified a novel interaction of DPP9 with Filamin A, which recruits DPP9 to Syk, a central kinase in B-cell signalling. Syk signalling can be terminated by degradation, requiring the ubiquitin E3 ligase Cbl. We show that DPP9 cleaves Syk to produce a neo N-terminus with serine in position 1. Pulse-chases combined with mutagenesis studies reveal that Ser1 strongly influences Syk stability. Furthermore, DPP9 silencing reduces Cbl interaction with Syk, suggesting that DPP9 processing is a prerequisite for Syk ubiquitination. Consistently, DPP9 inhibition stabilizes Syk, thereby modulating Syk signalling. Taken together, we demonstrate DPP9 as a negative regulator of Syk and conclude that DPP9 is a novel integral aminopeptidase of the N-end rule pathway.

Keywords